• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

Introduction to 6-Bromo-2-chloro-4-(difluoromethyl)-3-methylpyridine (CAS No. 1806030-98-7)

6-Bromo-2-chloro-4-(difluoromethyl)-3-methylpyridine, identified by its CAS number 1806030-98-7, is a highly versatile heterocyclic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound belongs to the pyridine family, a class of nitrogen-containing heterocycles that are widely recognized for their broad spectrum of biological activities and industrial applications. The structural features of 6-Bromo-2-chloro-4-(difluoromethyl)-3-methylpyridine, including the presence of bromo, chloro, and difluoromethyl substituents, make it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The bromo and chloro substituents on the pyridine ring introduce electrophilic centers, which are conducive for further functionalization through nucleophilic substitution reactions. This property is particularly useful in medicinal chemistry for constructing more complex molecular frameworks. Additionally, the difluoromethyl group is known to enhance metabolic stability and binding affinity in drug candidates, making it a preferred moiety in modern drug design.

In recent years, 6-Bromo-2-chloro-4-(difluoromethyl)-3-methylpyridine has been extensively studied for its potential applications in the development of novel therapeutic agents. The compound’s unique structural motifs have been leveraged in the synthesis of kinase inhibitors, antiviral agents, and anti-inflammatory drugs. For instance, derivatives of this compound have shown promising activity against tyrosine kinases, which are key targets in cancer therapy. The difluoromethyl group, in particular, has been demonstrated to improve the pharmacokinetic properties of small-molecule inhibitors by increasing lipophilicity and reducing susceptibility to metabolic degradation.

The bromo and chloro atoms also serve as handles for further derivatization, allowing chemists to explore a wide range of structural variations. This flexibility has enabled the development of libraries of compounds for high-throughput screening (HTS) campaigns aimed at identifying new drug candidates. Several studies have highlighted the utility of 6-Bromo-2-chloro-4-(difluoromethyl)-3-methylpyridine in fragment-based drug discovery, where it acts as a core scaffold for generating lead compounds with improved pharmacological profiles.

From an agrochemical perspective, this compound has been investigated for its potential as a precursor in the synthesis of novel pesticides and herbicides. The difluoromethyl group is particularly relevant in this context, as it is often associated with enhanced pesticidal activity due to its ability to modulate enzyme binding interactions. Researchers have reported the use of 6-Bromo-2-chloro-4-(difluoromethyl)-3-methylpyridine to develop compounds that exhibit potent activity against resistant pest strains, thereby addressing critical challenges in crop protection.

The synthesis of 6-Bromo-2-chloro-4-(difluoromethyl)-3-methylpyridine typically involves multi-step organic transformations starting from commercially available pyridine derivatives. Common synthetic routes include halogenation reactions followed by functional group interconversions to introduce the desired substituents. Advances in catalytic methods have further streamlined these processes, enabling higher yields and improved atom economy. For example, palladium-catalyzed cross-coupling reactions have been employed to efficiently incorporate the difluoromethyl group into the pyridine core.

In terms of applications in material science, this compound has been explored as a building block for designing organic electronic materials. The electron-withdrawing nature of the difluoromethyl group and the presence of halogen substituents make it a suitable candidate for constructing π-conjugated systems with tunable electronic properties. Such materials are relevant in the development of organic semiconductors and optoelectronic devices.

The growing interest in green chemistry has also influenced the synthesis strategies for 6-Bromo-2-chloro-4-(difluoromethyl)-3-methylpyridine. Researchers are increasingly adopting solvent-free conditions and catalytic methods to minimize waste and energy consumption. Additionally, biocatalytic approaches have been investigated as alternative routes to traditional synthetic methodologies, aligning with global efforts to promote sustainable chemical manufacturing.

In conclusion, 6-Bromo-2-chloro-4-(difluoromethyl)-3-methylpyridine (CAS No. 1806030-98-7) is a multifaceted compound with significant potential across multiple industries. Its structural features make it an invaluable intermediate in pharmaceutical research, while its derivatives offer promising solutions in agrochemicals and material science. As synthetic methodologies continue to evolve towards greener and more efficient processes, this compound will undoubtedly remain at the forefront of chemical innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)